BBH vs. XBI
BBH (VanEck Vectors Biotech ETF) and XBI (SPDR S&P Biotech ETF) are both Health & Biotech Equities funds - BBH tracks the MVIS US Listed Biotech 25 Index while XBI tracks the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, BBH returned 5.52%/yr vs 8.35%/yr for XBI. Their correlation of 0.80 suggests significant overlap in exposure. Both charge a 0.35% expense ratio.
Performance
BBH vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -3.98% return, which is significantly lower than XBI's 4.78% return. Over the past 10 years, BBH has underperformed XBI with an annualized return of 5.52%, while XBI has yielded a comparatively higher 8.35% annualized return.
BBH
- 1D
- -2.26%
- 1M
- -0.77%
- YTD
- -3.98%
- 6M
- -6.02%
- 1Y
- 22.25%
- 3Y*
- 5.36%
- 5Y*
- 0.21%
- 10Y*
- 5.52%
XBI
- 1D
- -4.39%
- 1M
- -2.04%
- YTD
- 4.78%
- 6M
- 8.21%
- 1Y
- 57.84%
- 3Y*
- 14.12%
- 5Y*
- 0.26%
- 10Y*
- 8.35%
BBH vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | -3.98% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
XBI SPDR S&P Biotech ETF | 4.78% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between BBH and XBI is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.77 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.80 |
Correlation (All Time) Calculated using the full available price history since Feb 7, 2006 | 0.80 |
The correlation between BBH and XBI has been stable across timeframes, ranging from 0.74 to 0.80 - a consistent structural relationship.
BBH vs. XBI - Sectors Allocation Comparison
Sectors
BBH
XBI
Healthcare
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBH
XBI
Basic Materials
BBH
-
XBI
Communication Services
BBH
-
XBI
-
Consumer Cyclical
BBH
-
XBI
-
Consumer Defensive
BBH
-
XBI
-
Energy
BBH
-
XBI
-
Financial Services
BBH
-
XBI
Industrials
BBH
-
XBI
-
Real Estate
BBH
-
XBI
-
Technology
BBH
-
XBI
-
Utilities
BBH
-
XBI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. XBI — Risk / Return Rank
BBH
XBI
BBH vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.18 | 2.28 | -1.10 |
Sortino ratioReturn per unit of downside risk | 1.77 | 3.14 | -1.37 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.37 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | 2.19 | 6.37 | -4.18 |
Martin ratioReturn relative to average drawdown | 5.64 | 19.55 | -13.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.18 | 2.28 | -1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | 0.01 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.25 | 0.26 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.36 | +0.02 |
Drawdowns
BBH vs. XBI - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for BBH and XBI.
Loading charts...
Drawdown Indicators
| BBH | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -63.89% | -8.81% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | -9.72% | -0.83% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -32.99% | +10.25% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -54.71% | +14.85% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -63.89% | +24.03% |
Current DrawdownCurrent decline from peak | -15.68% | -26.16% | +10.48% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -20.93% | +0.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.10% | 3.17% | +0.93% |
Volatility
BBH vs. XBI - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 5.79%, while SPDR S&P Biotech ETF (XBI) has a volatility of 9.43%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBH | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.79% | 9.43% | -3.64% |
Volatility (6M)Calculated over the trailing 6-month period | 14.21% | 20.31% | -6.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.91% | 25.57% | -6.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.47% | 32.17% | -10.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.16% | 32.00% | -9.84% |
BBH vs. XBI - Expense Ratio Comparison
Both BBH and XBI have an expense ratio of 0.35%.
Dividends
BBH vs. XBI - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.53%, more than XBI's 0.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.53% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
BBH and XBI have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.43%) compared to BBH (5.79%). In terms of maximum drawdown, BBH dropped -72.70% vs XBI's -63.89%.
On 10-year performance, XBI leads with 8.35% vs 5.52% for BBH. Both ETFs have the same 0.35% expense ratio. On volatility, BBH has been the lower-risk option at 5.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 8.35% return vs 5.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBH and XBI have the same expense ratio: 0.35% per year.
BBH has the higher dividend yield at 0.53%, compared with 0.34% for XBI.
BBH tracks MVIS US Listed Biotech 25 Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: VanEck and State Street.
XBI currently has the higher Sharpe Ratio (2.28 vs 1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBH and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer